Phase II trial of cabozantinib in patients with ocular melanoma.
Latest Information Update: 04 May 2012
At a glance
- Drugs Cabozantinib (Primary)
- Indications Eye neoplasms; Malignant melanoma
- Focus Therapeutic Use
- 04 May 2012 New trial record
Latest Information Update: 04 May 2012